Serum Apoptosis Markers in Acute Liver Failure: A Pilot Study

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 12, 2007, Pages 1477-1483

  Rutherford, Anna E ^a   Hynan, Linda S ^b   Borges, Carolina B S ^a   Forcione, David G ^a   Blackard, Jason T ^c   Lin, Wenyu ^a   Gorman, April R ^b   Shaikh, Obaid Shakil ^d   Reuben, Adrian ^e   Harrison, Edwyn ^f   Reddy, K Rajender ^g   Le, William M ^b   Chung, Raymond T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f MAYO CLINIC   (United States)

^g HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FAS ANTIGEN; INTERLEUKIN 6; M 30 ANTIGEN; PARACETAMOL; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER FAILURE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; LIVER; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36549015573     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.08.007     Document Type: Article

References (15)

1. Kass G.E., Macanas-Pirard P., Lee P.C., et al. The role of apoptosis in acetaminophen-induced liver injury. Ann N Y Acad Sci 1010 (2003) 557-559
2. El-Hassan H., Anwar K., Macanas-Pirard P., et al. Involvement of mitochondria in acetaminophen-induced apoptosis and hepatic injuryL Roles of cytochrome c, Bax, Bid and caspases. Toxicol Appl Pharmacol 181 (2003) 118-129
3. Galle P.R., Hofmann W.J., Walczak H., et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182 (1995) 1223-1230
4. Lacronique V., Mignon A., Fabre M., et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 2 (1996) 80-86
5. Bajt M.L., Lawson J.A., Vonderfecht S.L., et al. Protection against Fas receptor-mediated apoptosis in hepatocytes and nonparenchymal cells by a caspase-8 inhibitor in vivo: evidence for a postmitochondrial processing of caspase-8. Toxicol Sci 58 (2000) 109-117
6. Kosai K., Matsumoto K., Nagata S., et al. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 244 (1998) 683-690
7. Song le H., Binh V.Q., Duy D.N., et al. Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus. J Med Virol 73 (2004) 244-249
8. Ryo K., Kamogawa Y., Ikeda I., et al. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am J Gastroenterol 95 (2000) 2047-2055
9. Tagami A., Ohnishi H., Moriwaki H., et al. Fas-mediated apoptosis in acute alcoholic hepatitis. Hepatogastroenterology 50 (2003) 443-448
10. Strand S., Hofmann W.J., Grambihler A., et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med 4 (1998) 588-593
11. Tagami A., Ohnishi H., and Hughes R.D. Increased serum soluble Fas in patients with acute liver failure due to paracetamol overdose. Hepatogastroenterology 50 (2003) 742-745
12. Bantel H., Lugering A., Heidemann J., et al. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 40 (2004) 1078-1087
13. Ostapowicz G., Fontana R.J., Schiodt F.V., et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137 (2002) 947-954
14. Lapinski T.W., Kowalczuk O., Prokopowicz D., et al. Serum concentration of sFas and sFasL in healthy HbsAG carriers, chronic viral hepatitis B and C patients. World J Gastroenterol 24 (2004) 3650-3653
15. Kakiuchi Y., Yuki N., Iyoda K., et al. Circulating soluble Fas levels in patients with hepatitis C virus infection and interferon therapy. J Gastroenterol 12 (2004) 1189-1195